Minocycline Protection of Neomycin Induced Hearing Loss in Gerbils.

This animal study was designed to determine if minocycline ameliorates cochlear damage is caused by intratympanic injection of the ototoxic aminoglycoside antibiotic neomycin. Baseline auditory-evoked brainstem responses were measured in gerbils that received 40 mM intratympanic neomycin either with...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2015; pp. 1 - 9
Autores principales: Robinson, Alan M., Vujanovic, Irena, Richter, Claus-Peter
Formato: pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 4/8/2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109273912&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 109273912
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 4/8/2015
      vid: 2015
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        109273912
        109273912
        109273912
        10.1155/2015/934158
        109273912
      ppf: 1
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Minocycline Protection of Neomycin Induced Hearing Loss in Gerbils.
      aug:
        au:
          Robinson, Alan M.
          Vujanovic, Irena
          Richter, Claus-Peter
        affil: Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
      sug:
        subj:
          Neomycin Adverse Effects
          Hearing Disorders Chemically Induced
          Minocycline Therapeutic Use
          Drug Combinations Therapeutic Use
          Animal Studies
          Aminoglycosides Adverse Effects
          Hearing Disorders Prevention and Control
          Evoked Potentials, Auditory
          Fisher's Exact Test
          Analysis of Variance
          Post Hoc Analysis
          Ear Pathology
          Funding Source
      ab: This animal study was designed to determine if minocycline ameliorates cochlear damage is caused by intratympanic injection of the ototoxic aminoglycoside antibiotic neomycin. Baseline auditory-evoked brainstem responses were measured in gerbils that received 40 mM intratympanic neomycin either with 0, 1.2, or 1.5 mg/kg intraperitoneal minocycline. Four weeks later auditory-evoked brainstem responses were measured and compared to the baseline measurements. Minocycline treatments of 1.2 mg/kg and 1.5 mg/kg resulted in significantly lower threshold increases compared to 0 mg/kg, indicating protection of hearing loss between 6 kHz and 19 kHz. Cochleae were processed for histology and sectioned to allow quantification of the spiral ganglion neurons and histological evaluation of organ of Corti. Significant reduction of spiral ganglion neuron density was demonstrated in animals that did not receive minocycline, indicating that those receiving minocycline demonstrated enhanced survival of spiral ganglion neurons, enhanced survival of sensory hairs cells and spiral ganglion neurons, and reduced hearing threshold elevation correlates with minocycline treatment demonstrating that neomycin induced hearing loss can be reduced by the simultaneous application of minocycline.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N